深圳生物医药产业投资环境与发展规划讲解

Shenzhen’s biomedicine industry has formed a fine industrial foundation during the period of “Tenth Five-Year Plan”
一批跨国生物企业在深建有生产基地
A batch of multi-national biology enterprises have set up production bases at Shenzhen;
成果累累：世界第一个基因治疗药物、中国第一个生物工 程一类新药、中国第一台全自动生化分析仪、中国第一台 医用核磁共振诊断仪、中国第一台彩色B超等 Rich fruits: world’s first gene curing medicine, China’s first class-
one bioengineering medicine, China’s first auto biochemical analyzer, China’s first medical nuclear magnetic resonance diagnosis instrument and China’s first B-type color ultrasonic instrument, etc
Review 1 of the development of Shenzhen’s biomedicine industry
十五期间深圳生物医药产业已形成良好的产业基础
Shenzhen’s biomedicine industry has formed a fine industrial foundation during the period of “Tenth Five-Year Plan”
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
7
深圳市生物医药产业发展的历史回顾三
Review 3 of the development of Shenzhen’s biomedicine industry
第一批国家生物产业基地布点城市
5
深圳市生物医药产业发展的历史回顾二
Review 2 of the development of Shenzhen’s biomedicine industry
自主创新春苗出土
Emergence of self-creation
主体明确：初步形成了以市场为导向、以产业化为核心、以企 业为主体、以国内大学和研究机构为依托的技术创新体系，拥 有一批与国际技术水准接轨、按现代企业制度管理和运营的生 物医药研发企业
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
4
深圳市生物医药产业发展的历史回顾一
Review 1 of the development of Shenzhen’s biomedicine industry
十五期间深圳生物医药产业已形成良好的产业基础
2003年产值位居全国大中城市第3位; Output value in 2003 ranked 3rd among China’s big and medium cities.
2004年产值170.1亿元其中药品（含部分保健品）１２９亿元，较 上年增长１４％，医疗器械产品４１亿元，较上年增长５４％； Output value in 2004 was 17.01 billion yuan, there into medicine (including health products) are 12.9 billion, up by 14% over the previous year; medical instruments, up by 54% over the previous year;
深圳市生物医药产业发展的历史回顾 Review of the development of Shenzhen’s biomedicine industry
深圳市生物医药产业腾飞的现实机遇 Present opportunity for rapid development of Shenzhen’s biomedicine industry
Positioning: On the basis of Shenzhen’s current biomedicine industry, bringing the advantages of the large enterprises on high degree of concentration and internationalization an relatively complete market environment into full play, promote industrial gathering, realize scaled effect, push forward the construction of large biomedicine group and medium and small enterprises, enhance international competitiveness of the biomedicine industry, promote optimization and update of the regional industrial structure, strive to build Shenzhen into one of the world important R&D, production and export bases for biomedicines.
One of the base cities in the first batch of the State biomedicine industrialization
2005年6月5日，国家发改委正式认定深圳为首批三 个国家生物产业基地之一。
On 5 June, 2005, the National Development and Reform Commission officially affirmed Shenzhen as one of the 3 cities in the first batch of the State biomedicine production base.
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
8
深圳市生物医药产业发展的历史回顾三
Review 3 of the development of Shenzhen’s biomedicine industry
第一批国家生物产业基地布点城市
Definite objective: a technical creation system has basically formed with the market as orientation, industrialization as the core, enterprises as the main body, domestic universities and research institutes as the support. There is a batch of biomedicine R&D enterprises with international standard technology, and managing and operating according to modern corporate system.
One of the base cities in the first batch of the State biomedicine industrialization
定位：依托深圳现有的生物医药产业基础，发挥大型企业集中、国 际化程度高和市场环境相对完善的优势，促进产业集聚，实现规模 效应，推进大型生物医药企业集团和中小企业群建设，提高生物医 药产业的国际竞争力，带动区域产业结构优化升级，努力将深圳建 成世界重要的生物医药研发、生产和出口基地之一 。
如：赛诺菲安万特（sanofi aventis）、西门子、津村药业、 奥林 巴斯、美国安卫医仪、珀金－埃尔默等
E.g.: Sanofi Aventis, Siemens, Jincun Pharmacy, Olympus, Avail Medical Products, Inc. and PerkinElmer;
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
3
深圳市生物医药产业发展的历史回顾一
Review 1 of the development of Shenzhen’s biomedicine industry
十五期间深圳生物医药产业已形成良好的产业基础
自主创新春苗出土
Emergence of self-creation
人才汇聚：拥有了一批具有创新精神的生物产业高级人才 Gathering of talents: Lots of senior specialists with creation spirit
engaged in biology industry
深圳市科技和信息局
Shenzhen Bureau of Science, Technology & Information
Jan. 20, 2006
2021/4/15
© 2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
内容提要 Content
深圳市发展生物医药产业的工作重点 Key points for developing Shenzhen’s biomedicine industry
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
2
深圳市生物医药产业发展的历史回顾一
如：三九、健康元、迈瑞、海王、一致、科兴、康泰、尚荣等 E.g.: 999, Joincare, Mindray, Neptunus, Accord, Kexing,
Kangtai and Shangrong.
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
如：赛百诺、微芯生物、翰宇生物、海普瑞等
E.g.: Sibiono, Chipscreen, Hybio and Hepalink
©2005 SHENZHEN BUREAU OF SCIENCE, TECHNOLOGY & INFORMATION
6
深圳市生物医药产业发展的历史回顾二
Review 2 of the development of Shenzhen’s biomedicine industry
中国生命科学高峰论坛
China Life Sciences Partnering Forum--Shenzhen
深圳生物医药产业投资环境与发展规划
Investment environment and development planning for Shenzhen Biomedicine Industry
深圳市生物医药“十一五”期间发展目标 Development objectiveLeabharlann Baiduof Shenzhen’s biomedicine during the period of “Eleventh Five-Year Plan”
深圳市生物医药“十一五”规划四大重点支持领域 key support fields for Shenzhen’s biomedicine during the “Eleventh Five-Year Plan” planning
Shenzhen’s biomedicine industry has formed a fine industrial foundation during the period of “Tenth Five-Year Plan”
一批本土企业成长为深圳乃至国内本领域龙头
A batch of local enterprises have become the leader of the sector at Shenzhen and even in China as well;